Objective This study aimed to assess the efficacy and safety of prophylactic tranexamic acid
administration vs standard uterotonic agents alone among women undergoing cesarean …

Importance Tranexamic acid is widely available and used off-label in patients with bleeding
traumatic injury, although the literature does not consistently agree on its efficacy and safety …

Introduction Over the last decade, tranexamic acid (TXA) has been incorporated into
treatment algorithms for a multitude of emergent conditions and the evidence surrounding its …

Background Postpartum hemorrhage (PPH) is one of the important risk factors leading to
maternal mortality and intervention is essential. Oxytocin therapy is widely used clinically …

A focused assessment with sonography in trauma examination is positive for free fluid in the
right upper quadrant. There is no evidence of pneumothorax on ultrasound. Her pelvis is …

Objective To conduct a systematic review and meta-analysis of all randomized controlled
trials (RCTs) that inspected the efficacy and safety of prophylactic TXA compared with …

A 33 year old woman in the fourth month of pregnancy is referred to the emergency
department because of spontaneous massive antepartum haemorrhage. On admission her …

Background Prehospital administration of tranexamic acid (TXA) to injured patients is
increasing worldwide. However, optimal TXA dose and need of a second infusion on …

Tranexamic acid (TXA), a fibrinolytic agent, effectively inhibits plasminogen activation,
thereby reducing fibrinolysis and hemorrhage. This study focused on its application in …

Tranexamic acid (TXA) is an antifibrinolytic drug that reduces bleeding by inhibiting
plasminogen activation and fibrin clot degradation. Its role in prehospital trauma …